Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 64 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

27%

17 trials in Phase 3/4

Results Transparency

0%

0 of 13 completed trials have results

Key Signals

21 recruiting

Enrollment Performance

Analytics

N/A
13(31.7%)
Phase 4
9(22.0%)
Phase 3
8(19.5%)
Phase 2
4(9.8%)
Phase 1
4(9.8%)
Early Phase 1
3(7.3%)
41Total
N/A(13)
Phase 4(9)
Phase 3(8)
Phase 2(4)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (64)

Showing 20 of 64 trials
NCT06284642Phase 4Recruiting

Early Lumbar Drainage Plus Intrathecal Urokinase in Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK)

Role: collaborator

NCT06155032Not ApplicableRecruiting

Rescue Endovascular Therapy for Progressive Acute Mild Ischemic Stroke With Large Vascular Occlusion

Role: collaborator

NCT07544459Not ApplicableCompleted

Mindfulness-based Stress Reduction Combined With Aerobic Training in Cardiac Rehabilitation After Percutaneous Coronary Intervention: A Dual Impact on Kinesiophobia and Heart Rate Variability

Role: lead

NCT07495111Not ApplicableRecruiting

Prophylactic PS Placement to Prevent Pancreatitis After Endoscopic Transpapillary GPC for Cholelithiasis With Concomitant Choledocholithiasis

Role: collaborator

NCT05578300Recruiting

Effective Translation of Endovascular Thrombectomy Trials Into Real-world Practice in the Asia-Pacific

Role: collaborator

NCT07444099Not ApplicableEnrolling By Invitation

Early Postoperative Intervention in Gastric Cancer Patients

Role: collaborator

NCT07413068Recruiting

Treatment Outcomes and Complications of Three Therapeutic Approaches for Concomitant Choledocholithiasis and Cholecystolithiasis

Role: collaborator

NCT07410403Enrolling By Invitation

AI-Based Fine Morphological Subtyping of Myeloma Single Cells for Predicting FISH Abnormalities

Role: collaborator

NCT07379190Phase 3Not Yet Recruiting

HR-MRI-Directed Tirofiban Therapy for Late-Window Acute Ischemic Stroke (TIAN)

Role: collaborator

NCT07379268Recruiting

Evaluation of the Efficacy of Anti-HER2 Antibody-Drug Conjugates (ADC) in Locally Advanced or Metastatic Bladder Cancer Based on Organoid Technology.

Role: collaborator

NCT07379281Recruiting

Evaluating the Efficacy of Neoadjuvant Chemotherapy Drugs Based on Organoid Technology

Role: collaborator

NCT07379255Recruiting

Evaluation of Postoperative Adjuvant Chemotherapy Efficacy for Bladder Cancer Based on Organoid Technology.

Role: collaborator

NCT06221371Phase 3Completed

Endovascular Treatment With or Without Preceding Intravenous Tenecteplase (TNK) in Patients With Late-window acUte Ischemic Stroke Due to Middle Cerebral Artery Occlusion

Role: collaborator

NCT05896826Recruiting

Magnetocardiography in the Accurate Identification of Myocardial Infarction

Role: collaborator

NCT06197724Recruiting

MCG for Identification of Myocardial Ischemia in Suspected NSTE-ACS Patients

Role: collaborator

NCT07153744Phase 4Not Yet Recruiting

Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction

Role: collaborator

NCT07152886Phase 4Not Yet Recruiting

The Effects of Clostridium Butyricum on Adverse Events During Adjuvant Chemotherapy for Colorectal Cancer

Role: collaborator

NCT05993884Phase 1Completed

Safety and Preliminary Efficacy of Allogeneic Endothelial Progenitor Cells (EPCs) in Patients With Acute Ischemic Stroke

Role: collaborator

NCT05659641Not ApplicableActive Not Recruiting

The Branch-based Intraoperative Stent System in the Treatment of Stanford A Aortic Dissection(BROAD)

Role: collaborator

NCT06061185Recruiting

Multimodal Computed Tomography in Patients With Acute Hemorrhagic Stroke

Role: collaborator